• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL

Catalog number BNC882491-500

Price for BNC882491-500

Sign In for Pricing

Size / count 1x 500 µL

About this product

AKT1 is a 62 kDa protein and member of the serine/threonine kinase AKT family. AKT1 is also known as Protein Kinase B (PKB) or Rac Protein Kinase Alpha. The Akt family also includes AKT2. Activation of AKT1 by insulin or insulin-growth factor-1 (IGF-1) results in phosphorylation of both Thr 308 and Ser 473. AKT proteins become phosphorylated and activated in insulin/IGF-1-stimulated cells by an upstream kinase (s), and the activation of AKT1 and AKT2 is inhibited by the PI kinase inhibitor wortmannin. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number
BNC882491-500
Size / count
1x 500 µL
Dry ice
No
Hazardous
No
Discontinued
No
CAS Number
9007-83-4
Synonyms
AKT1; PKB; Protein Kinase B Alpha; RAC-alpha serine/threonine-protein kinase
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
AKT1
Gene ID
207
NCBI Gene ID
525622
UniProt
P31749
Swiss Prot
P31749
Host
Mouse
Species Reactivity
Human
Reactivity
AKT1
Immunogen
Recombinant fragment of human AKT1 protein (around aa 85-189) (exact sequence is proprietary)
Target Antigen
AKT1
Clonality
Monoclonal
Clone
AKT1/2491
Type
Primary
Source
Animal
Origin
Animal
Applications
IHC, FFPE (verified) |WB (verified)
Positive Control
PDGF-treated NIH/3T3 cells. HeLa cell lysates. Human pancreas or cervical carcinoma.
Stability
2 years
Concentration
0.1 mg/mL
Buffer
PBS, 0.1% BSA, 0.05% azide
Molecular Weight
62 kDa
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Notes
Protect from light
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgG2b, kappa
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
0.05% sodium azide (CAS 26628-22-8)
Conjugate
CF488A

Frequently Asked Questions

What is the catalog number for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL?

The catalog number for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL is BNC882491-500.

What sizes are available for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL?

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.

Is AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL in stock?

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL?

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL?

Estimated delivery time for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL?

The safety data sheet for AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF488A conjugate, 0.1mg/mL used for?

AKT1 is a 62 kDa protein and member of the serine/threonine kinase AKT family. AKT1 is also known as Protein Kinase B (PKB) or Rac Protein Kinase Alpha. The Akt family also includes AKT2. Activation of AKT1 by insulin or insulin-growth factor-1 (IGF-1) results in phosphorylation of both Thr 308 and

What is the recommended dilution for this antibody?

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

What is the recommended storage temperature after reconstitution?

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Can this product be used in multiplex assays?

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

You Might Also Like
CD7 (T3-3A1), CF405S conjugate, 0.1mg/mL
CD7 (T3-3A1), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040978-500
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470977-100
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC400253-100
CD45RO (190-2F2.5), CF647 conjugate, 0.1mg/mL
CD45RO (190-2F2.5), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471081-100
HSP27 (G3.1), CF740 conjugate, 0.1mg/mL
HSP27 (G3.1), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740861-500
CD8 (C8/1035), CF568 conjugate, 0.1mg/mL
CD8 (C8/1035), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC681035-500
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC400352-100
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC400994-100